Wave Life Sciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Go back to Wave Life Sciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

WAVE Life Sciences (WVE) Tops Q4 EPS by 2c, Revenues Miss

March 4, 2021 7:13 AM EST

WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of ($0.59), $0.02 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $9.44 million versus the consensus estimate of $9.75 million.

Wave is entering 2021 with depth and diversity throughout our pipeline and platform, the result of focused and deliberate execution, and a steadfast commitment to leading a... More